Literature DB >> 16358585

Molecular factors required for human immunodeficiency virus type I infectivity.

A G Bukrinskaya1, G K Vorkunova, M E Burshteĭn, T V Gorodnicheva, M Stevenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16358585     DOI： 10.1007/s10630-005-0124-8

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  13 in total

1.  In vitro assembly of human immunodeficiency virus type 1 Gag protein.

Authors:  Y Morikawa; T Goto; K Sano
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

2.  HIV-1 matrix protein p17 resides in cell nuclei in association with genomic RNA.

Authors:  A G Bukrinskaya; G K Vorkunova
Journal:  AIDS Res Hum Retroviruses       Date:  1992-10       Impact factor: 2.205

3.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 4.  HIV-1 assembly and maturation.

Authors:  A G Bukrinskaya
Journal:  Arch Virol       Date:  2004-03-05       Impact factor: 2.574

5.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 6.  HIV-1 gag proteins: diverse functions in the virus life cycle.

Authors:  E O Freed
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

7.  The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.

Authors:  M Shehu-Xhilaga; M Hill; J A Marshall; J Kappes; S M Crowe; J Mak
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.

Authors:  F Li; R Goila-Gaur; K Salzwedel; N R Kilgore; M Reddick; C Matallana; A Castillo; D Zoumplis; D E Martin; J M Orenstein; G P Allaway; E O Freed; C T Wild
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205

9.  Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation.

Authors:  Jing Zhou; Xiong Yuan; David Dismuke; Brett M Forshey; Christopher Lundquist; Kuo-Hsiung Lee; Christopher Aiken; Chin Ho Chen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.

Authors:  H G Kräusslich; M Fäcke; A M Heuser; J Konvalinka; H Zentgraf
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.